Expansion of HIV/AIDS Vaccine Program Announced by GeoVax Labs, Inc.
by
Health: Hearsay & HeadlinesPosted
Mon 11 Apr 2011 12:00am
/PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), announced today that it is expanding its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and the HIV Vaccine Trials Network (HVTN). Specifically, ...
Read on »
A Novel Strategy for Development of an Effective HIV/AIDS Vaccine
by
nih.govPosted
Thu 28 Apr 2011 8:00pm
Description of Invention:
The invention offered for licensing and commercial development relates to the field of HIV/AIDS Vaccines. More specifically, the invention describes a novel strategy that can be useful in effective vaccination and treatment of HIV/AIDS infected persons. In this strategy (called ‘trigger-and-neutralize ...
Read on »
Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials
by
Medline PlusPosted
Mon 19 Jul 2010 3:00am
Almost half get the erroneous result, causing stigma and hampering trial enrollment, experts say
Monday, July 19, 2010
SUNDAY, July 18 (HealthDay News) -- Almost half of HIV-negative people who participate in clinical trials for HIV vaccines end up testing positive on routine HIV tests -- even though t ...
Read on »
AIDS vaccine focus shifts after ...
by
Dr. Rubens D.Posted
Tue 14 Oct 2008 4:58am
AIDS vaccine focus shifts after disappointments
By Andrew Quinn
13 oct 2008--A global AIDS vaccine conference this week will seek fresh strategies against the HIV virus, with experts weighing the value of basic laboratory research against large-scale human clinical trials after a string of disappointments.
Approaches focusing on " ...
Read on »
Aarkstore Enterprise International AIDS Vaccine Initiative - Product Pipeline Review - Q4 2010
by
AarkstorePosted
Tue 11 Jan 2011 10:47am
Aarkstore announce a new report "International AIDS Vaccine Initiative - Product Pipeline Review - Q4 2010" through its vast collection of market research report.
“International AIDS Vaccine Initiative - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on cur ...
Read on »
AIDS Vaccine: Maybe not Effective After All
by
Paul SaxPosted
Mon 12 Oct 2009 10:03pm
Well, that didn’t take long:
Researchers from the U.S. Army and Thailand announced last month they had found the first vaccine that provided some protection against HIV. But a second analysis of the $105 million study, not disclosed publicly, suggests the results may have been a fluke, according to AIDS scientists who have seen it.
In s ...
Read on »